CORRECTION - Annual Changes to the NASDAQ Biotechnology Index

December 15, 2014 8:05 PM | 27 seconds read | Make a Comment

NEW YORK, Dec. 15, 2014 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by The NASDAQ OMX Group, Inc. NDAQ the ticker and exchange for Esperion Therapeutics, Inc. should read ESPR (sted Nasdaq:EXPR).

NDAQG

CONTACT: Media Contacts: Joseph Christinat, Nasdaq +1.646.441.5121 Josh Machiz, Nasdaq +1.212.231.5614 Issuer & Investor Contact: Natasha Selzer, Nasdaq +1.301.978.8623

Market News and Data brought to you by Benzinga APIs

Posted In: Press Releases

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!